Who Qualifies for Semaglutide Injections for Weight Loss?
Semaglutide injections are used as an anti-obesity medication and used for long-term weight management. If you are interested in more information, or if this chronic weight management treatment would be right for you, visit Mediworks Rejuvenation Centre today. Contact us today for more information or schedule an appointment online. We are conveniently located at Unit #103 – 15222 32nd Avenue Diversion, Surrey, BC V3Z 0R8, Canada.
Table of Contents:
To qualify for Semaglutide weight loss treatment, patients must meet certain medical criteria. First, patients must have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one obesity-related comorbidity, such as type 2 diabetes, high blood pressure, or sleep apnea. Second, patients must have a medical history free of contraindications, such as a history of pancreatitis, thyroid cancer, or multiple endocrine neoplasia syndrome type 2.
In addition to meeting medical criteria, patients must also be willing to make significant lifestyle changes to support their weight loss goals. This includes dietary modifications, such as reducing calorie intake and avoiding high-fat and high-sugar foods. Patients must also engage in regular physical activity, such as walking, jogging, or strength training. Finally, patients must be committed to making long-term lifestyle changes to maintain their weight loss results.
Semaglutide weight loss treatment can be an effective option for patients with obesity who meet certain medical criteria and are willing to make significant lifestyle changes. However, patients must also be aware of the potential risks and side effects associated with this treatment. By working closely with their healthcare provider and making long-term lifestyle changes, patients can achieve their weight loss goals and improve their overall health.
Obesity is a major public health concern that affects millions of people worldwide. Semaglutide, a medication originally developed to treat type 2 diabetes, has recently been approved by the FDA as a weight loss treatment. However, not everyone is eligible for this treatment.
Semaglutide is an approved chronic weight management shot for anyone ages 12 and older. To get approved for Semaglutide shots, you will need to have an initial BMI at or above the 95th percentile for your sex and age. Semaglutide shots may also be used in conjunction with other weight loss methods including lifestyle changes, like exercise, a healthy diet, and a calorie deficit.
Semaglutide may not be suitable for patients with a history of heart disease, heart failure, or stroke due to its potential risk of myocardial ischemia caused by hypotension. Additionally, patients with prolonged QT intervals or other arrhythmias may also be at risk. A study published in the Journal of the American College of Cardiology found that Semaglutide use was associated with an increased risk of cardiovascular events in patients with type 2 diabetes and cardiovascular disease. Therefore, it is important to consider the patient’s cardiovascular history before prescribing Semaglutide.
Patients with a history of inflammatory bowel disease or intestinal obstruction should avoid Semaglutide use due to the potential risk of exacerbating these conditions. Additionally, patients with gastroparesis or other motility disorders may also be at risk. A study published in the Journal of Diabetes Investigation found that Semaglutide use was associated with an increased risk of pancreatitis or pancreatic cancer. Therefore, it is important to consider the patient’s gastrointestinal history before prescribing Semaglutide.
Patients with a history of hypersensitivity to Semaglutide or its components should avoid Semaglutide use. Additionally, patients with end-stage renal disease requiring dialysis may not be suitable for Semaglutide use. A study published in the Journal of Diabetes and Its Complications found that patients with impaired renal or hepatic function may be at risk of hypoglycemia when using Semaglutide. Therefore, it is important to consider the patient’s overall health status before prescribing Semaglutide.
During the 16- to 20-week treatment period, the dose of the Semaglutide drug needs to be increased to an effective level of 2.4 mg to include weight loss benefits among other benefits, and reduce the impact of common side effects such as gastrointestinal disorders.
Come to Mediworks Rejuvenation Centre for more information. To get help with your weight loss, call us today to book an appointment. We look forward to serving you! We serve patients from South Surrey BC, White Rock Surrey BC, Cloverdale Surrey BC, Campbell Heights Surrey BC, Surrey Newton Surrey BC, Crescent Beach Surrey BC, South Newton Surrey BC, and surrounding areas!